EFFICACY OF BRIVARACETAM IN PEDIATRIC EPILEPSY: AN UP-TO-DATE
Among the newest antiepileptic drugs, brivaracetam (BRV), previously known as “ucb34714”, is one of the most interesting molecules available, increasingly getting the attention of researchers. The clinical efficacy of BRV as adjunctive therapy has been extensively assessed in six randomized, control...
Enregistré dans:
Auteur principal: | Antonio Nicotera |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Associazione Italiana Giovani Medici
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8a459c6dc1de4afab53dabd6fdeebd23 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A review of the pharmacology and clinical efficacy of brivaracetam
par: Klein P, et autres
Publié: (2018) -
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
par: Feyissa AM
Publié: (2019) -
Overnight switch from levetiracetam to brivaracetam. Safety and tolerability
par: L. Abraira, et autres
Publié: (2021) -
Effects of 12-month Antiepileptic Drug Use on Thyroid Functions in Children: A Retrospective Observational Study
par: Fatma Hancı, et autres
Publié: (2021) -
Plasma Homocysteine Level in Children under Treatment with Antiepileptic Drugs and its Relation to Intelligence Quotient
par: Mohammed Abo Al-maaty, et autres
Publié: (2020)